secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROKIDNEY CORP. (PROK)
CIK:        0001850270
Form:       8-K
Filed at:   2025-05-30T23:59:59+00:00
Accession:  0000950170-25-079685
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

ProKidney shareholders approve reincorporation from Cayman Islands to Delaware
------------------------------------------------------------------------------

- Domestication approved with 227.6M for, 1.1M against; expected completion by end of Q3 2025.
- New Delaware charter adopted; authorized shares set at 700M Class A, 500M Class B, 50M preferred.
- Directors Culleton, Legorreta, Sinha elected to three-year terms (avg ~226M for each).
- Ernst & Young ratified as independent auditor for fiscal year 2025 (238.6M for).
- Advisory charter proposals approved, including exclusive forum, written consent removal, supermajority vote requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850270/000095017025079685/0000950170-25-079685-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850270/000095017025079685/prok-20250530.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-079685

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer